Breaking News, Trials & Filings

Trials & Filings in Brief: Oct. 30, 2013

Acacia, Flexion, GSK KaloBios, MannKind, Merrimack, RedHill, Spectrum, Theravance

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Phase II
Acacia begins CINV trial . . . read more

Flexion posts good OA results . . . read more

Merrimack ovarian cancer treatment falls short . . . read more

Spectrum completes enrollment for melphalan trial . . . read more

Phase III
RedHill starts H.pylori trial . . . read more

Filings
KaloBios gets orphan designation for CF treatment . . . read more

FDA Accepts Afrezza Submission . . . read more

Launches
GSK, Theravance launch Breo Ellipta . . . read more

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters